Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Oct;81(4):654–661. doi: 10.1038/sj.bjc.6690743

Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo

S Kauppila 1, M K Bode 1, F Stenbäck 2, L Risteli 1, J Risteli 1
PMCID: PMC2362884  PMID: 10574251

Abstract

Malignant tumours often induce a fibroproliferative response in the adjacent stroma, characterized by increased expression of type I and type III procollagens. In normal tissues, fibrillar collagens normally undergo extensive intermolecular cross-linking that provides tensile strength to the tissue. Here we set out to characterize collagen cross-linking in human ovarian carcinoma tissue in vivo. Biochemical and immunochemical methods were used for cross-linked telopeptides of type I and III collagens in samples of benign and malignant serous tumours. The locations and staining patterns of these proteins were visualized immunohistochemically. The contents of both total collagen and the cross-linked type I and type III collagens in the malignant samples were only about 20% of those in the benign tumours. The cross-linked telopeptide antigens derived from the collagens were smaller and more heterogeneous in size in the malignant than in the benign tumours, indicating a defective cross-linking process scarcely leading to the formation of mature cross-links in the collagen fibres in malignancy. Immunostaining revealed disorganized type I and type III collagen bundles in carcinomas. These findings suggest that the collagen cross-linking process is aberrant in malignant tumours, possibly resulting in increased susceptibility of tumour collagens for the proteolysis often associated with tumour invasion. © 1999 Cancer Research Campaign

Keywords: collagen, ovarian neoplasms, invasion

Full Text

The Full Text of this article is available as a PDF (344.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aznavoorian S., Murphy A. N., Stetler-Stevenson W. G., Liotta L. A. Molecular aspects of tumor cell invasion and metastasis. Cancer. 1993 Feb 15;71(4):1368–1383. doi: 10.1002/1097-0142(19930215)71:4<1368::aid-cncr2820710432>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  2. Birk D. E., Zycband E. I., Winkelmann D. A., Trelstad R. L. Collagen fibrillogenesis in situ. Discontinuous segmental assembly in extracellular compartments. Ann N Y Acad Sci. 1990;580:176–194. doi: 10.1111/j.1749-6632.1990.tb17928.x. [DOI] [PubMed] [Google Scholar]
  3. Bode M. K., Mosorin M., Satta J., Risteli L., Juvonen T., Risteli J. Complete processing of type III collagen in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 1999 Jun;19(6):1506–1511. doi: 10.1161/01.atv.19.6.1506. [DOI] [PubMed] [Google Scholar]
  4. Contente S., Kenyon K., Rimoldi D., Friedman R. M. Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science. 1990 Aug 17;249(4970):796–798. doi: 10.1126/science.1697103. [DOI] [PubMed] [Google Scholar]
  5. Cronlund A. L., Smith B. D., Kagan H. M. Binding of lysyl oxidase to fibrils of type I collagen. Connect Tissue Res. 1985;14(2):109–119. doi: 10.3109/03008208509015017. [DOI] [PubMed] [Google Scholar]
  6. Desmoulière A., Darby I., Costa A. M., Raccurt M., Tuchweber B., Sommer P., Gabbiani G. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab Invest. 1997 Jun;76(6):765–778. [PubMed] [Google Scholar]
  7. Dvorak H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986 Dec 25;315(26):1650–1659. doi: 10.1056/NEJM198612253152606. [DOI] [PubMed] [Google Scholar]
  8. Eyre D. R., Paz M. A., Gallop P. M. Cross-linking in collagen and elastin. Annu Rev Biochem. 1984;53:717–748. doi: 10.1146/annurev.bi.53.070184.003441. [DOI] [PubMed] [Google Scholar]
  9. Feres-Filho E. J., Menassa G. B., Trackman P. C. Regulation of lysyl oxidase by basic fibroblast growth factor in osteoblastic MC3T3-E1 cells. J Biol Chem. 1996 Mar 15;271(11):6411–6416. doi: 10.1074/jbc.271.11.6411. [DOI] [PubMed] [Google Scholar]
  10. Fleischmajer R., Perlish J. S., Timpl R. Collagen fibrillogenesis in human skin. Ann N Y Acad Sci. 1985;460:246–257. doi: 10.1111/j.1749-6632.1985.tb51172.x. [DOI] [PubMed] [Google Scholar]
  11. Furcht L. T., Skubitz A. P., Fields G. B. Tumor cell invasion, matrix metalloproteinases, and the dogma. Lab Invest. 1994 Jun;70(6):781–783. [PubMed] [Google Scholar]
  12. Fushida-Takemura H., Fukuda M., Maekawa N., Chanoki M., Kobayashi H., Yashiro N., Ishii M., Hamada T., Otani S., Ooshima A. Detection of lysyl oxidase gene expression in rat skin during wound healing. Arch Dermatol Res. 1996;288(1):7–10. doi: 10.1007/BF02505035. [DOI] [PubMed] [Google Scholar]
  13. Gui G. P., Puddefoot J. R., Vinson G. P., Wells C. A., Carpenter R. In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix. Br J Surg. 1995 Sep;82(9):1192–1196. doi: 10.1002/bjs.1800820914. [DOI] [PubMed] [Google Scholar]
  14. Hart I. R., Saini A. Biology of tumour metastasis. Lancet. 1992 Jun 13;339(8807):1453–1457. doi: 10.1016/0140-6736(92)92039-i. [DOI] [PubMed] [Google Scholar]
  15. Hauptmann S., Zardi L., Siri A., Carnemolla B., Borsi L., Castellucci M., Klosterhalfen B., Hartung P., Weis J., Stöcker G. Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms. Lab Invest. 1995 Aug;73(2):172–182. [PubMed] [Google Scholar]
  16. Iozzo R. V. Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue. Lab Invest. 1995 Aug;73(2):157–160. [PubMed] [Google Scholar]
  17. Kauppila S., Saarela J., Stenbäck F., Risteli J., Kauppila A., Risteli L. Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas. Am J Pathol. 1996 Feb;148(2):539–548. [PMC free article] [PubMed] [Google Scholar]
  18. Kelley J., Chrin L., Evans J. N. Microquantitation of insoluble tissue collagen (types I and III) by radiodilution assay. Anal Biochem. 1984 May 15;139(1):115–125. doi: 10.1016/0003-2697(84)90396-8. [DOI] [PubMed] [Google Scholar]
  19. Kenyon K., Contente S., Trackman P. C., Tang J., Kagan H. M., Friedman R. M. Lysyl oxidase and rrg messenger RNA. Science. 1991 Aug 16;253(5021):802–802. doi: 10.1126/science.1678898. [DOI] [PubMed] [Google Scholar]
  20. Kivirikko K. I., Laitinen O., Prockop D. J. Modifications of a specific assay for hydroxyproline in urine. Anal Biochem. 1967 May;19(2):249–255. doi: 10.1016/0003-2697(67)90160-1. [DOI] [PubMed] [Google Scholar]
  21. Laiho M., Keski-Oja J. Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res. 1989 May 15;49(10):2533–2553. [PubMed] [Google Scholar]
  22. Liotta L. A., Kohn E. Cancer invasion and metastases. JAMA. 1990 Feb 23;263(8):1123–1126. [PubMed] [Google Scholar]
  23. Melkko J., Kauppila S., Niemi S., Risteli L., Haukipuro K., Jukkola A., Risteli J. Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem. 1996 Jun;42(6 Pt 1):947–954. [PubMed] [Google Scholar]
  24. Peyrol S., Raccurt M., Gerard F., Gleyzal C., Grimaud J. A., Sommer P. Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma. Am J Pathol. 1997 Feb;150(2):497–507. [PMC free article] [PubMed] [Google Scholar]
  25. Reiser K., McCormick R. J., Rucker R. B. Enzymatic and nonenzymatic cross-linking of collagen and elastin. FASEB J. 1992 Apr;6(7):2439–2449. doi: 10.1096/fasebj.6.7.1348714. [DOI] [PubMed] [Google Scholar]
  26. Ricard-Blum S., Bresson-Hadni S., Guerret S., Grenard P., Volle P. J., Risteli L., Grimaud J. A., Vuitton D. A. Mechanism of collagen network stabilization in human irreversible granulomatous liver fibrosis. Gastroenterology. 1996 Jul;111(1):172–182. doi: 10.1053/gast.1996.v111.pm8698196. [DOI] [PubMed] [Google Scholar]
  27. Ricard-Blum S., Esterre P., Grimaud J. A. Collagen cross-linking by pyridinoline occurs in non-reversible skin fibrosis. Cell Mol Biol (Noisy-le-grand) 1993 Nov;39(7):723–727. [PubMed] [Google Scholar]
  28. Risteli J., Elomaa I., Niemi S., Novamo A., Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem. 1993 Apr;39(4):635–640. [PubMed] [Google Scholar]
  29. Risteli J., Niemi S., Trivedi P., Mäentausta O., Mowat A. P., Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem. 1988 Apr;34(4):715–718. [PubMed] [Google Scholar]
  30. Stetler-Stevenson W. G., Aznavoorian S., Liotta L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol. 1993;9:541–573. doi: 10.1146/annurev.cb.09.110193.002545. [DOI] [PubMed] [Google Scholar]
  31. Stetler-Stevenson W. G. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol. 1996 May;148(5):1345–1350. [PMC free article] [PubMed] [Google Scholar]
  32. Stetler-Stevenson W. G., Liotta L. A., Kleiner D. E., Jr Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 1993 Dec;7(15):1434–1441. doi: 10.1096/fasebj.7.15.8262328. [DOI] [PubMed] [Google Scholar]
  33. Whalen G. F. Solid tumours and wounds: transformed cells misunderstood as injured tissue? Lancet. 1990 Dec 15;336(8729):1489–1492. doi: 10.1016/0140-6736(90)93188-u. [DOI] [PubMed] [Google Scholar]
  34. Zhu G. G., Risteli J., Puistola U., Kauppila A., Risteli L. Progressive ovarian carcinoma induces synthesis of type I and type III procollagens in the tumor tissue and peritoneal cavity. Cancer Res. 1993 Oct 15;53(20):5028–5032. [PubMed] [Google Scholar]
  35. Zhu G. G., Risteli L., Mäkinen M., Risteli J., Kauppila A., Stenbäck F. Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms. Cancer. 1995 Feb 15;75(4):1010–1017. doi: 10.1002/1097-0142(19950215)75:4<1010::aid-cncr2820750417>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  36. Zhu G. G., Stenbäck F., Risteli L., Risteli J., Kauppila A. Organization of type III collagen in benign and malignant ovarian tumors. An immunohistochemical study. Cancer. 1993 Sep 1;72(5):1679–1684. doi: 10.1002/1097-0142(19930901)72:5<1679::aid-cncr2820720531>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  37. van der Stappen J. W., Hendriks T., Wobbes T. Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors. Int J Cancer. 1990 Jun 15;45(6):1071–1078. doi: 10.1002/ijc.2910450616. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES